.svg){kind=small}
Aug-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Kind Medicine has shown a consistent performance in the Tincture & Sublingual category in California. The brand secured the 19th position in May, July, and August 2025, indicating a stable presence in the state's competitive market. However, it's noteworthy that Kind Medicine did not make it into the top 30 rankings in June. This could suggest a temporary dip in performance or increased competition during that month. Despite this, the sales figures reveal a positive trend, with an increase from May to July, suggesting a recovery from the June absence in the rankings.
The performance of Kind Medicine across other states and categories is not detailed here, but the data from California provides valuable insights into the brand's market dynamics. The consistent ranking in three out of four months highlights a certain level of consumer loyalty and brand recognition in the Tincture & Sublingual category. The absence from the top 30 in June is a potential area of concern, which may require further analysis to understand the underlying factors. This pattern of consistent yet fluctuating performance might be reflective of broader trends affecting the cannabis industry in California and possibly in other states where Kind Medicine operates.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in California, Kind Medicine has maintained a consistent presence, ranking 19th in May, July, and August of 2025. Despite a brief absence from the top 20 in June, Kind Medicine's sales have shown resilience, with a slight increase from July to August. In contrast, Breez has demonstrated a steady upward trajectory, improving its rank from 18th to 17th between May and June, accompanied by a notable increase in sales. Meanwhile, Carter's Aromatherapy Designs (C.A.D.) has experienced a downward trend, dropping from 14th in May to 17th in August, with sales reflecting a similar decline. Saida, although absent from the top 20 in May and June, made a strong comeback, ranking 20th in July and climbing to 16th in August, with a significant boost in sales. These dynamics suggest that while Kind Medicine remains a steady player, competitors like Breez and Saida are gaining momentum, potentially impacting Kind Medicine's market share and necessitating strategic adjustments to enhance its competitive positioning.
Notable Products
In August 2025, the Sativa Tincture (800mg THC, 30ml) maintained its position as the top-performing product for Kind Medicine, with sales reaching 147 units. The Indica Capsules 10-Pack (300mg) saw a significant rise, moving from no rank in previous months to secure the second position in August. The CBD:THC 20:1 Tincture Drops (450mg CBD, 22.4mg THC 30ml) ranked third, although it dropped from second place in July. Sativa Capsules 2-Pack (60mg) experienced a slight decline, falling to fourth place from its third position in June. Indica Tincture Drops (800mg THC, 30ml) rounded out the top five, indicating a consistent demand for tinctures and sublingual products.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
